Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

How Is Cochlear (ASX:COH) Advancing Hearing Implant Technology Worldwide?

Cochlear Limited (ASX:COH) has established itself as one of the world's leading medical device companies specialising in implantable hearing technologies. Through decades of research, product development and clinical collaboration, the company has helped expand access to hearing solutions for people with hearing loss across …

Aditi Sarkar | 26 July 2026

Can CSL (ASX:CSL) Continue Strengthening Its Global Healthcare Leadership?

CSL Limited (ASX:CSL) is one of Australia's largest healthcare companies and a globally recognised biotechnology business. Through its operations across plasma-derived therapies, vaccines and speciality pharmaceuticals, the company serves patients in more than 100 countries. Continued investment in research, manufacturing and innovation has enabled …

Aditi Sarkar | 25 July 2026

4DMedical (ASX:4DX) Shares Closed Down Today: What Are Investors Watching?

4DMedical Ltd (ASX:4DX) closed on 24 July 2026 at AUD 3.11 after recording a decline of 4.01%, or AUD 0.13, during the latest trading session. The movement came as the broader healthcare sector also faced selling pressure, with the S&P/ASX 200 Health Care (ASX:XHJ) …

Aditi Sarkar | 24 July 2026

Can PYC Therapeutics (ASX:PYC) Maintain Momentum After 28.68% Yearly Growth?

PYC Therapeutics Ltd (ASX:PYC) closed trading on 24 July 2026 at AUD 1.66, recording a decline of 0.90% during the session. The company’s share price decreased by AUD 0.015 on the day, while maintaining a positive annual performance, with shares remaining up 28.68% over …

Aditi Sarkar | 24 July 2026

Ramsay Health Care (ASX:RHC): What Does the Recent Dip Signal for Investors?

Ramsay Health Care Ltd (ASX:RHC) closed trading on 24 July 2026 at AUD 42.30, recording a marginal decline of 0.07% during the session. The company’s share price decreased by AUD 0.03 on the day, while maintaining positive longer-term performance, with shares remaining up 9.10% …

Aditi Sarkar | 24 July 2026

Mesoblast (ASX:MSB) Slides to $2.22 After Remaining Under Pressure Over the Year

Mesoblast Ltd (ASX:MSB) traded lower on 24 July 2026, with shares closing at AUD 2.22, representing a decline of 4.31% or AUD 0.100 during the session.

Aditi Sarkar | 24 July 2026

Cochlear (ASX:COH) Down 64% Over One Year as Market Reassesses Valuation and Growth Expectations

Cochlear Ltd (ASX:COH) closed on 24 July 2026 at AUD 111.61, declining 0.45% or AUD 0.50 during the session. The movement occurred alongside weakness across the broader healthcare sector, with the S&P/ASX 200 Health Care (ASX:XHJ) index trading at 25,198.50 points, down 0.95% today.

Aditi Sarkar | 24 July 2026

Argent Biopharma (ASX:RGT) Falls 12% as Healthcare Stock Extends Annual Loss to 37%

Highlights• RGT shares fell 12.28% to AUD 0.05.• Market capitalisation is approximately AUD 5.83 million.• Session turnover was AUD 14,220.• The 12-month return stands at -36.71%, reflecting persistent investor caution.Argent Biopharma Ltd (ASX:RGT) declined 12.28% in the latest session, with shares closing at AUD …

Aditi Sarkar | 24 July 2026

Starpharma Holdings (ASX:SPL): The Pharmaceutical Innovator Behind One of the ASX's Strongest Healthcare Returns

Starpharma Holdings Ltd (ASX:SPL) has delivered one of the more notable one-year share price performances on the ASX, with the stock rising approximately 666.67% over the twelve months to 24 July 2026. The stock traded at AUD 0.69 during the session on 24 July …

Sonal Goyal | 24 July 2026

4DMedical (ASX:4DX): The Lung Imaging Technology Company Redefining What an ASX Healthcare Rally Looks Like

4DMedical Ltd (ASX:4DX) has delivered one of the more notable one-year share price performances on the ASX, with the stock rising approximately 1,096.15% over the twelve months to 24 July 2026. The stock traded at AUD 3.11 during the session on 24 July 2026. …

Sonal Goyal | 24 July 2026
Support

Hi! How can we help you today?

Loading…